Lazo-Langner A, Louzada M, Garg A, et al. Assessing the risk-benefit of anticoagulants in elkderly patients with cancer-associated venous thromboembolism; a population based study. EHA 2017, abstract S441.
Besparing door inzet biosimilars loopt op tot bijna 800 miljoen per jaar
mei 2024